ARTICLES BY JIM KREMIDAS

• Why Site Relationships With Sponsors and CROs Must Evolve Now

  11/24/2025

  Sites are central to drug development — we cannot run a trial without them — yet the industry continues to treat them as tactical, temporary instruments. It’s time to break this cycle, implores Jim Kremidas, executive director, Association of Multisite Research Corporations (AMRC).

• One And Done: How Bad Is The PI Turnover Problem?

  11/21/2018

  It’s ruefully referred to throughout the clinical trial industry as the “one and done” phenomenon, and it’s a problem that has plagued us for years. The term refers to physicians and other medical professionals who jump into a trial to assume the duties of principal investigators (PIs). Unfortunately, many are completely or relatively inexperienced in clinical trials; they’ve taken on the role of PI in hope of adding a new revenue stream to their practice or boosting their academic credentials.

• The Time Is Now To Professionalize The Clinical Trial Workforce

  8/30/2018

  Donna was the office manager for a trucking company. Terri worked at the reception desk of a contract research organization (CRO) straight out of high school. Tom lost his job teaching history at a community college after a round of layoffs. Jessica earned her living at a local hair salon.